567 related articles for article (PubMed ID: 28478033)
21. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.
Altafaj X; Dierssen M; Baamonde C; Martí E; Visa J; Guimerà J; Oset M; González JR; Flórez J; Fillat C; Estivill X
Hum Mol Genet; 2001 Sep; 10(18):1915-23. PubMed ID: 11555628
[TBL] [Abstract][Full Text] [Related]
22. DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives.
Neumann F; Gourdain S; Albac C; Dekker AD; Bui LC; Dairou J; Schmitz-Afonso I; Hue N; Rodrigues-Lima F; Delabar JM; Potier MC; Le Caër JP; Touboul D; Delatour B; Cariou K; Dodd RH
Sci Rep; 2018 Feb; 8(1):2859. PubMed ID: 29434250
[TBL] [Abstract][Full Text] [Related]
23. Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndrome.
Corrales A; Parisotto EB; Vidal V; García-Cerro S; Lantigua S; Diego M; Wilhem Filho D; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N
Behav Brain Res; 2017 Sep; 334():142-154. PubMed ID: 28743603
[TBL] [Abstract][Full Text] [Related]
24. Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A.
Nguyen TL; Duchon A; Manousopoulou A; Loaëc N; Villiers B; Pani G; Karatas M; Mechling AE; Harsan LA; Limanton E; Bazureau JP; Carreaux F; Garbis SD; Meijer L; Herault Y
Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30115750
[TBL] [Abstract][Full Text] [Related]
25. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
[TBL] [Abstract][Full Text] [Related]
26. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome.
Giacomini A; Stagni F; Emili M; Guidi S; Salvalai ME; Grilli M; Vidal-Sanchez V; Martinez-Cué C; Bartesaghi R
Brain Res Bull; 2018 Jun; 140():378-391. PubMed ID: 29935232
[TBL] [Abstract][Full Text] [Related]
27. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.
Lockrow J; Boger H; Bimonte-Nelson H; Granholm AC
Behav Brain Res; 2011 Aug; 221(2):610-22. PubMed ID: 20363261
[TBL] [Abstract][Full Text] [Related]
28. Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A.
Pons-Espinal M; Martinez de Lagran M; Dierssen M
Neurobiol Dis; 2013 Dec; 60():18-31. PubMed ID: 23969234
[TBL] [Abstract][Full Text] [Related]
29. The GABA
Block A; Ahmed MM; Rueda N; Hernandez MC; Martinez-Cué C; Gardiner KJ
Neuroscience; 2018 Feb; 372():192-212. PubMed ID: 29292072
[TBL] [Abstract][Full Text] [Related]
30. Re-establishment of the epigenetic state and rescue of kinome deregulation in Ts65Dn mice upon treatment with green tea extract and environmental enrichment.
De Toma I; Ortega M; Catuara-Solarz S; Sierra C; Sabidó E; Dierssen M
Sci Rep; 2020 Sep; 10(1):16023. PubMed ID: 32994493
[TBL] [Abstract][Full Text] [Related]
31. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model.
Walker JM; Klakotskaia D; Ajit D; Weisman GA; Wood WG; Sun GY; Serfozo P; Simonyi A; Schachtman TR
J Alzheimers Dis; 2015; 44(2):561-72. PubMed ID: 25318545
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome.
García-Cerro S; Martínez P; Vidal V; Corrales A; Flórez J; Vidal R; Rueda N; Arbonés ML; Martínez-Cué C
PLoS One; 2014; 9(9):e106572. PubMed ID: 25188425
[TBL] [Abstract][Full Text] [Related]
33. Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene.
García-Cerro S; Vidal V; Lantigua S; Berciano MT; Lafarga M; Ramos-Cabrer P; Padro D; Rueda N; Martínez-Cué C
Neurobiol Dis; 2018 Feb; 110():206-217. PubMed ID: 29221819
[TBL] [Abstract][Full Text] [Related]
34. EGCG-like non-competitive inhibitor of DYRK1A rescues cognitive defect in a down syndrome model.
Delabar JM; Gomes MAGB; Fructuoso M; Sarrazin N; George N; Fleary-Roberts N; Sun H; Bui LC; Rodrigues-Lima F; Janel N; Dairou J; Maria EJ; Dodd RH; Cariou K; Potier MC
Eur J Med Chem; 2024 Feb; 265():116098. PubMed ID: 38171148
[TBL] [Abstract][Full Text] [Related]
35. Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice.
Nakano-Kobayashi A; Awaya T; Kii I; Sumida Y; Okuno Y; Yoshida S; Sumida T; Inoue H; Hosoya T; Hagiwara M
Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10268-10273. PubMed ID: 28874550
[TBL] [Abstract][Full Text] [Related]
36. Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A.
Guedj F; Sébrié C; Rivals I; Ledru A; Paly E; Bizot JC; Smith D; Rubin E; Gillet B; Arbones M; Delabar JM
PLoS One; 2009; 4(2):e4606. PubMed ID: 19242551
[TBL] [Abstract][Full Text] [Related]
37. The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model.
Valenti D; de Bari L; de Rasmo D; Signorile A; Henrion-Caude A; Contestabile A; Vacca RA
Biochim Biophys Acta; 2016 Jun; 1862(6):1093-104. PubMed ID: 26964795
[TBL] [Abstract][Full Text] [Related]
38. Forebrain Shh overexpression improves cognitive function and locomotor hyperactivity in an aneuploid mouse model of Down syndrome and its euploid littermates.
Gao FJ; Klinedinst D; Fernandez FX; Cheng B; Savonenko A; Devenney B; Li Y; Wu D; Pomper MG; Reeves RH
Acta Neuropathol Commun; 2021 Aug; 9(1):137. PubMed ID: 34399854
[TBL] [Abstract][Full Text] [Related]
39. DYRK1A Overexpression Alters Cognition and Neural-Related Proteomic Pathways in the Hippocampus That Are Rescued by Green Tea Extract and/or Environmental Enrichment.
De Toma I; Ortega M; Aloy P; Sabidó E; Dierssen M
Front Mol Neurosci; 2019; 12():272. PubMed ID: 31803016
[TBL] [Abstract][Full Text] [Related]
40. Adult-onset fluoxetine treatment does not improve behavioral impairments and may have adverse effects on the Ts65Dn mouse model of Down syndrome.
Heinen M; Hettich MM; Ryan DP; Schnell S; Paesler K; Ehninger D
Neural Plast; 2012; 2012():467251. PubMed ID: 22848851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
